Therefore, to investigate whether the regulation of lipid metabolism and thus the anti-NAFLD effect of E1231 was mediated by SIRT1, we added EX527 to the FFA-challenged HepG2 and AML12 cell lipid accumulation model. Here, SIRT1 is linked to metabolic dysfunction-associated steatotic liver disease.